Director, Oncology Bioanalytical Strategy Lead
AstraZeneca - US - Cambridge Kendall SQ - MA
Posted Oct 28, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- 175K-263K From the posting source checked Nov 17, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Director Plus From the posting source checked Nov 17, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered From the posting source checked Nov 17, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Director, Oncology Bioanalytical Strategy Lead US - Cambridge Kendall SQ - MA As part of the Integrated Bioanalysis (IBA) Global Team, you will be responsible for leading the design and implementation of robust bioanalytical strategies, including, but not limited to, endpoints such as pharmacokinetics (PK), immunogenicity, and biomarkers to support the AstraZeneca pipeline. You will be closely involved in supporting selected oncology portfolio programs by engaging with key stakeholder functions on project teams and subteams, developing holistic bioanalytical strategies, and working closely with internal and external laboratory and CRO teams to ensure the development and validation of assays aligned with their intended context of use. You will serve as the IBA project lead for selected programs, ensuring the development of sound bioanalytical assay designs and their implementation. This will involve close collaboration with IBA scientific and technical laboratory staff, as well as cross-functional stakeholders. The ideal candidate will have a strong track record in regulated bioanalysis supporting therapeutic modalities in oncology and immuno-oncology. Experience supporting antibody-drug conjugates, radioconjugates, or T-cell engagers (TCEs), in addition to traditional biologics, and a background in immunology and immunogenicity are highly desirable. In this dynamic, matrixed environment, you will be responsible for managing stakeholder expectations, contributing to project strategy and delivery, and serving as the primary interface with highly skilled bioanalytical scientists within IBA and our partner laboratories. You will have the opportunity to make an immediate and lasting impact on our diverse pipeline. The IBA group within Clinical Pharmacology and Safety Sciences provides broad
Read the full description at astrazeneca.wd3.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Director, Biotech Strategy Lead - Oncology
ICON plc - US, Blue Bell (ICON)
Associate Director, Antisense Oligonucleotide Analytical Development
Biogen - Cambridge, MA
Senior Director Oncology Commercial Strategy Biomarkers
Bristol Myers Squibb - Princeton - NJ - US
Director, Global Pharmacovigilance Operations Lead
Sarepta Therapeutics - Cambridge, MA